FindTrial
Sign In

Retrospective evaluation of clinical efficacy of prolonged intermittent renal replacement therapy for severe acute kidney injury

Retrospective evaluation of clinical efficacy of prolonged intermittent renal replacement therapy for severe acute kidney injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022035
Enrollment
Unknown
Registered
2019-03-21
Start date
2019-04-10
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Interventions

Renal function recovery group + non-recovery group:PIRRT

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The date of admission is from October 1, 2008 to September 30, 2018. 2. Diagnostic criteria for patients with AKI (KDIGO AKI definition in 2012): one of the following: 1) Scr increased more than 26.5 umol/L within 48 hours; 2) Scr increased more than 1.5 times the baseline - confirmed or speculated to occur within 7 days; 3) urine volume < 0.5 ml/(kg.h), and lasted more than 6 hours. Obstructive nephropathy or dehydration were excluded. 3. Treated with PIRRT .

Exclusion criteria

Exclusion criteria: 1. Patients who had been diagnosed with chronic kidney disease (CKD) above stage 4 or had received dialysis before AKI occurred; 2. Patients who have received other types of RRT such as CRRT, IHD and PD after AKI; 3. Patients who lost follow-up within 30 days after PIRRT ended.

Design outcomes

Primary

MeasureTime frame
case fatality rate;serum creatinine;Glomerular filtration rate;—

Countries

China

Contacts

Public ContactRong Shu
goldenxc@126.com+86 13681811669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026